The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Jul 24, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 7
- 0 vs. Q1 2023
- Portfolio value
- $257.7M
- −$18.9M (−6.8%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 2,577,220 | $68.9M | 26.8% | −2,000,620−43.7% | Reduced | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $55.2M | 21.4% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,680,621 | $50.1M | 19.5% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 18,136,735 | $47.0M | 18.2% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,568,181 | $27.7M | 10.7% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 9,414,795 | $5.18M | 2.0% | +166,666+1.8% | Added | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,309,329 | $3.58M | 1.4% | 00.0% | Unchanged | History |